Annual CFF
$28.71 M
-$17.66 M-38.08%
March 31, 2024
Summary
- As of February 8, 2025, LSB annual cash flow from financing activities is $28.71 million, with the most recent change of -$17.66 million (-38.08%) on March 31, 2024.
- During the last 3 years, LSB annual CFF has fallen by -$80.40 million (-73.69%).
- LSB annual CFF is now -73.69% below its all-time high of $109.11 million, reached on March 1, 2021.
Performance
LSB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
N/A
September 1, 2024
Summary
- LSB quarterly cash flow from financing activities is not available.
Performance
LSB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
September 1, 2024
Summary
- LSB TTM cash flow from financing activities is not available.
Performance
LSB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LSB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.1% | - | - |
| 3 y3 years | -73.7% | - | - |
| 5 y5 years | -73.7% | - | - |
LSB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.7% | at low | ||||
| 5 y | 5-year | -73.7% | at low | ||||
| alltime | all time | -73.7% | at low |
LakeShore Biopharma Co Ltd Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $28.71 M(-38.1%) | - | - |
| Sep 2023 | - | $6.20 M(-18.2%) | $6.20 M(-18.2%) |
| Mar 2023 | $46.37 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $7.58 M | $7.58 M |
| Mar 2022 | $56.75 M(-48.0%) | - | - |
| Mar 2021 | $109.11 M | - | - |
FAQ
- What is LakeShore Biopharma Co Ltd annual cash flow from financing activities?
- What is the all time high annual CFF for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd annual CFF year-on-year change?
- What is the all time high quarterly CFF for LakeShore Biopharma Co Ltd?
- What is the all time high TTM CFF for LakeShore Biopharma Co Ltd?
What is LakeShore Biopharma Co Ltd annual cash flow from financing activities?
The current annual CFF of LSB is $28.71 M
What is the all time high annual CFF for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high annual cash flow from financing activities is $109.11 M
What is LakeShore Biopharma Co Ltd annual CFF year-on-year change?
Over the past year, LSB annual cash flow from financing activities has changed by -$17.66 M (-38.08%)
What is the all time high quarterly CFF for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high quarterly cash flow from financing activities is $7.58 M
What is the all time high TTM CFF for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high TTM cash flow from financing activities is $7.58 M